Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Humacyte (HUMA)
NASDAQ:HUMA
Holding HUMA?
Track your performance easily
Humacyte (HUMA) Ownership Overview
5.93% Insiders
6.22% Mutual Funds
3.21% Other Institutional Investors
10.37% ETFs
74.27% Public Companies and Individual Investors
The ownership structure of Humacyte (HUMA) stock is a mix of institutional, retail, and individual investors. Approximately 19.80% of the company’s stock is owned by Institutional Investors, 5.93% is owned by Insiders, and 74.27% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 04, 2024 | Michael T. Constantino Director | xxxxxxxxxxxxx | $20148 |
| Nov 21, 2024 | Brady W Dougan Director | xxxxxxxxxxxxx | $7979 |
| Nov 21, 2024 | Laura E Niklason Pres, Ceo & Dir,director | xxxxxxxxxxxxx | $7979 |
| Nov 20, 2024 | Brady W Dougan Director | xxxxxxxxxxxxx | $6606799 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $177534 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $424298 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $972497 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $4616024 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,793,847 | Institution | 3.73% | 22,243,450 | |
| 4,362,123 | Institution | 3.39% | 20,240,251 | |
| 3,825,018 | Institution | 2.97% | 17,748,084 | |
| 3,633,136 | Insider | 2.82% | 16,857,751 | |
| 3,633,136 | Insider | 2.82% | 16,857,751 | |
| 2,790,585 | Institution | 2.17% | 12,948,314 | |
| 1,007,237 | Institution | 0.78% | 4,673,580 | |
| 984,304 | Institution | 0.76% | 4,567,171 | |
| 848,534 | Institution | 0.66% | 3,937,198 | |
| 811,358 | Institution | 0.63% | 3,764,701 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,825,018 | Institution | 2.97% | 17,748,084 | |
| 1,007,237 | Institution | 0.78% | 4,673,580 | |
| 984,304 | Institution | 0.76% | 4,567,171 | |
| 811,358 | Institution | 0.63% | 3,764,701 | |
| 446,467 | Institution | 0.35% | 2,071,607 | |
| 278,788 | Institution | 0.22% | 1,293,576 | |
| 252,783 | Institution | 0.20% | 1,172,913 | |
| 69,109 | Institution | 0.05% | 320,666 | |
| 50,925 | Institution | 0.04% | 236,292 | |
| 50,642 | Institution | 0.04% | 234,979 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,592,815 | Institution | 2.02% | 13,093,716 | |
| 2,551,683 | Institution | 1.98% | 11,839,809 | |
| 2,518,513 | Institution | 1.96% | 8,714,055 | |
| 1,227,471 | Institution | 0.95% | 6,198,729 | |
| 808,029 | Institution | 0.63% | 3,749,255 | |
| 635,778 | Institution | 0.49% | 2,950,010 | |
| 402,690 | Institution | 0.31% | 2,033,585 | |
| 428,872 | Institution | 0.33% | 1,483,897 | |
| 277,241 | Institution | 0.22% | 1,400,067 | |
| 219,595 | Institution | 0.17% | 1,018,921 |
FAQ
Who Owns Humacyte (HUMA)?
According to the latest TipRanks data, approximately 3.21% of the company's stock is held by institutional investors, 5.93% is held by insiders, and 74.27% is held by retail investors.
What percentage of Humacyte (HUMA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.21% of Humacyte (HUMA) stock is held by institutional investors.
What percentage of Humacyte (HUMA) stock is held by retail investors?
According to the latest TipRanks data, approximately 74.27% of Humacyte (HUMA) stock is held by retail investors.
Who owns the most shares of Humacyte (HUMA)?
Vanguard owns the most shares of Humacyte (HUMA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.